Ricardo Gazzinelli to Recombinant Proteins
This is a "connection" page, showing publications Ricardo Gazzinelli has written about Recombinant Proteins.
Connection Strength
0.230
-
Dos Santos LI, Galv?o-Filho B, de Faria PC, Junqueira C, Dutra MS, Teixeira SM, Rodrigues MM, Ritter G, Bannard O, Fearon DT, Antonelli LR, Gazzinelli RT. Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1. Cancer Immunol Immunother. 2015 Mar; 64(3):311-23.
Score: 0.099
-
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, G?mez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP. A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. J Clin Microbiol. 2025 May 14; 63(5):e0199924.
Score: 0.051
-
Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares IS. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol?) as adjuvant. Vaccine. 2024 Apr 02; 42(9):2394-2406.
Score: 0.047
-
Santos ARRD, Serufo ?V, Figueiredo MM, Godoi LC, Vit?rio JG, Marcelino AP, Avelar DM, Rodrigues FTG, Machado-Coelho GLL, Medeiros FAC, Jer?nimo SMB, Oliveira EJ, Nascimento FC, Teixeira SMR, Gazzinelli RT, Nagem RAP, Fernandes AP. Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis. Mem Inst Oswaldo Cruz. 2019 Feb 04; 114:e180405.
Score: 0.033